ELMD Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Electromed Inc (ELMD) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The company's strong financial performance, positive analyst rating, and lack of negative catalysts make it a solid choice for long-term growth. While technical indicators are neutral, the overall fundamentals and sentiment support a buy decision.
The MACD histogram is -0.246, below 0, and negatively contracting, indicating a weak bearish trend. RSI is at 40.213, in the neutral zone, suggesting no clear overbought or oversold conditions. Moving averages are converging, showing no strong directional trend. Key support is at 23.263, and resistance is at 25.341.
Strong financial performance in Q2 2026, with revenue up 16.25% YoY, net income up 40.29% YoY, and EPS up 45.45% YoY.
Analyst rating upgrade by Roth Capital with a price target increase to $38, indicating confidence in the company's growth potential.
Neutral sentiment from hedge funds and insiders, with no significant trading trends.
Lack of recent news or event-driven catalysts.
In Q2 2026, Electromed Inc reported revenue of $18.897 million, up 16.25% YoY. Net income increased to $2.761 million, up 40.29% YoY. EPS rose to 0.32, a 45.45% YoY increase. Gross margin improved slightly to 78.42%, up 0.95% YoY.
Roth Capital recently raised the price target for ELMD to $38 from $36 and maintained a Buy rating, citing strong performance in the company's core homecare business.
